Related Experiment Video
Updated: Apr 16, 2026

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections
Published on: August 30, 2014
Polio inactivated vaccine costs into routine childhood immunization in Brazil
Insights
Introducing inactivated polio vaccine in Brazil increased annual costs by 49.2%. This cost analysis for vaccination regimens found the new vaccine regimen was more expensive than the oral polio vaccine-only program.
Area of Science:
- Public Health
- Vaccinology
- Health Economics
Background:
- Brazil's National Immunization Program utilizes oral polio vaccine (OPV).
- Introduction of inactivated polio vaccine (IPV) is being considered for routine immunization.
- Cost-effectiveness of different vaccination strategies is crucial for program planning.
Purpose of the Study:
- To analyze the costs associated with introducing inactivated polio vaccine (IPV) into Brazil's routine immunization schedule.
- To compare the costs of various IPV-inclusive vaccination regimens against the current OPV-only regimen.
- To estimate the financial impact of IPV introduction on the National Immunization Program.
Main Methods:
- A cost analysis was performed on five vaccination regimens, including IPV, compared to an OPV-only regimen.
- Vaccine costs were estimated for routine immunization, National Immunization Days, and strategic IPV stock.
- Costs were calculated based on 2011 figures.
Main Results:
- The annual cost of the OPV-only program was estimated at US$19,873,170.
- Incremental costs for IPV inclusion varied based on dosage, presentation, and National Immunization Days.
- A regimen with two IPV doses, three OPV doses, and one National Immunization Day cost US$29,653,539.
- Replacing DTPw/Hib and HepB with pentavalent vaccine allowed IPV introduction without increasing injections or visits.
Conclusions:
- Introduction of IPV increased annual polio vaccine costs by 49.2% compared to the OPV-only regimen.
- This cost increase represented 1.13% of the National Immunization Program's vaccine purchase expenditure in 2011.
- Strategic vaccine procurement and regimen planning are essential for managing the costs of IPV introduction.
Abstract:
OBJECTIVE To analyze the costs of vaccination regimens for introducing inactivated polio vaccine in routine immunization in Brazil. METHODS A cost analysis was conducted for vaccines in five vaccination regimens, including inactivated polio vaccine, compared with the oral polio vaccine-only regimen. The costs of the vaccines were estimated for routine use and for the "National Immunization Days", during when the oral polio vaccine is administered to children aged less than five years, independent of their vaccine status, and the strategic stock of inactivated polio vaccine. The presented estimated costs are of 2011. RESULTS The annual costs of the oral vaccine-only program (routine and two National Immunization Days) were estimated at US$19,873,170. The incremental costs of inclusion of the inactivated vaccine depended on the number of vaccine doses, presentation of the vaccine (bottles with single dose or ten doses), and number of "National Immunization Days" carried out. The cost of the regimen adopted with two doses of inactivated vaccine followed by three doses of oral vaccine and one "National Immunization Day" was estimated at US$29,653,539. The concomitant replacement of the DTPw/Hib and HepB vaccines with the pentavalent vaccine enabled the introduction of the inactivated polio without increasing the number of injections or number of visits needed to complete the vaccination. CONCLUSIONS The introduction of the inactivated vaccine increased the annual costs of the polio vaccines by 49.2% compared with the oral vaccine-only regimen. This increase represented 1.13% of the expenditure of the National Immunization Program on the purchase of vaccines in 2011.
More Related Videos
10:42Design to Implementation Study for Development and Patient Validation of Paper-Based Toehold Switch Diagnostics
Published on: June 17, 2022
13:47Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens
Published on: May 19, 2020
Related Concept Videos
Vaccinations
Vaccines
Vaccine Production
Drug Dosing: Infants and Children
Preventive Healthcare Services
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...